Influence
July 1, 2025

Shortening the Patient Health Questionnaire–9—When Brief Scales May Suffice

Kurt Kroenke, MD

Published in JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Kurt Kroenke, MD

A new depression screening tool, the Quick PHQ-3 (QP-3), has been developed as a streamlined version of the widely used 9-item Patient Health Questionnaire (PHQ-9). The QP-3 includes just three items—interest, depressed mood and self-esteem—and demonstrated 98% sensitivity and 76% specificity in identifying moderate or greater depression symptoms.

The tool was evaluated using data from over 96,000 respondents across all 50 U.S. states. The study employed advanced psychometric techniques and was conducted in four waves to ensure reliability across a demographically diverse population. The QP-3’s performance was found to be comparable to longer instruments such as the 4-item PHQ-Dep-4.

Although the QP-3 has not yet been validated against structured psychiatric interviews, its utility is promising in scenarios where brief assessments are necessary. These include mobile health applications, large-scale health screenings or research settings where depression is a secondary outcome.

The full PHQ-9 remains the preferred tool when comprehensive evaluation is required. It captures the full range of diagnostic criteria for major depressive disorder, tracks residual symptoms, includes a critical item on suicidal ideation and supports treatment decisions based on established severity cutoffs.

Additionally, a “gated” approach—using a single-item screener followed by the remaining items only when necessary—has shown potential to cut response burden by nearly half without compromising accuracy.

The availability of brief validated screeners like the QP-3 enhances options for mental health assessment across diverse settings and populations.

Authors:

Kurt Kroenke1,2

Affiliations

1Division of General Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis

2Regenstrief Institute Inc, Indianapolis, Indiana

Partners

Related News

Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability

Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability

INDIANAPOLIS, US and LONDON, UK – Regenstrief Institute and SNOMED International have released LOINC® Ontology 2.0, the next version

Kurt Kroenke, M.D., and Paul Musey, M.D., M.S.

Treating anxiety could curb unnecessary ED visits for low-risk chest pain

Chest pain ranks as the second most common reason for emergency department (ED) visits, making it a key concern

Dr. Rachel Patzer, Dr. Virginia Caine, Claire Fiddian-Green and Phaedra Schaffer-Corso

Regenstrief leaders join 2025 Leadership Exchange delegation in Washington, D.C.

Regenstrief Institute President and Chief Executive Officer Rachel Patzer, PhD, MPH, was part of a contingent of more than